Search

Your search keyword '"Prostatic tumor"' showing total 135 results
Start Over "Prostatic tumor" Publication Type News
135 results on '"Prostatic tumor"'

1. Findings on Carcinoid Tumor Detailed by Researchers at Urology Department (Robot-assisted Radical Prostatectomy Due to a Primary Carcinoid Prostatic Tumor in a Three-Year-Old Child: A Case Report)

Subjects
Elsevier Science Inc., Periodical publishing, Cystic fibrosis -- Research, Robotic surgery, Robots, Tumors -- Research, Carcinoid tumor -- Research, Surgery, Recurrence (Disease), Cancer research, Cancer, Chromosomes, Respiratory tract diseases, Failure to thrive, Fibrosis, Infection, Editors, Constipation, Robot, Business, Health, Health care industry
Abstract

2019 NOV 26 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Carcinoid Tumor is the subject of a report. According to [...]

Published
2019

2. Researchers at Hanyang University College of Medicine Release New Data on Trichomoniasis (Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men)

Subjects
Tumors -- Comparative analysis, Trichomoniasis -- Comparative analysis, Sexually transmitted diseases -- Comparative analysis, Cancer, Infection, Editors, Business, Health, Health care industry
Abstract

2019 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Sexually Transmitted Diseases and Conditions (STDs) - Trichomoniasis. According to [...]

Published
2019

3. Inducible nitric oxide synthase activity inhibits prostatic tumor growth

Subjects
University of Cincinnati, Interferon -- Growth, Tumors, Gene therapy, Biological response modifiers, Cancer -- Care and treatment -- Genetic aspects, Nitric oxide, Health, Science and technology, Company growth, Growth
Abstract

According to a study from the United States, inducible nitric oxide synthase (iNOS) activity is essential for inhibition of prostatic tumor growth by interferon (IFN)-beta gene therapy. "We have previously [...]

Published
2006

4. Inducible nitric oxide synthase activity inhibits prostatic tumor growth

Subjects
University of Cincinnati, Interferon -- Growth, Tumors, Cell research, Gene therapy, Biological response modifiers, Cancer -- Care and treatment -- Genetic aspects, Nitric oxide, Health, Company growth, Growth
Abstract

According to a study from the United States, inducible nitric oxide synthase (iNOS) activity is essential for inhibition of prostatic tumor growth by interferon (IFN)-beta gene therapy. "We have previously [...]

Published
2006

5. Inducible nitric oxide synthase activity inhibits prostatic tumor growth

Subjects
Company growth, University of Cincinnati -- Growth, Gene therapy -- Growth, Tumors -- Growth, Biological response modifiers -- Growth, Interferon -- Growth, Nitric oxide -- Growth, Cell research -- Growth, Cancer -- Care and treatment, Cancer -- Growth, Cancer -- Genetic aspects
Abstract

According to a study from the United States, inducible nitric oxide synthase (iNOS) activity is essential for inhibition of prostatic tumor growth by interferon (IFN)-beta gene therapy. "We have previously [...]

Published
2006

6. Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration

Author

Bladou, F., Vessella, R.L., Buhler, K.R., Ellis, W.J., True, L.D., and Lange, P.H.

Subjects
Cell death -- Measurement -- Physiological aspects, Castration -- Physiological aspects -- Measurement, Prostate cancer -- Development and progression, Health, Physiological aspects, Development and progression, Measurement
Abstract

Bladou, F.; Vessella, R.L.; Buhler, K.R.; Ellis, W.J.; True, L.D.; Lange, P.H. 'Cell Proliferation and Apoptosis during Prostatic Tumor Xenograft Involution and Regrowth after Castration.' International Journal of Cancer, September [...]

Published
1996

7. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon

Author

Israeli, R.S., Grob, M., and Fair, W.R.

Subjects
Prostate cancer -- Diagnosis -- Analysis, Tumor markers -- Analysis -- Diagnosis, Health, Diagnosis, Analysis
Abstract

Israeli, R.S.; Grob, M.; Fair, W.R.'Prostate-Specific Membrane Antigen and Other Prostatic Tumor Markers on the Horizon.' Urologic Clinics of North America, May 1997;24(2):439. According to the authors' abstract of an [...]

Published
1997

8. Differential responses to cytokine gene therapy of prostatic tumor cells implanted orthotopically or subcutaneously

Author

Yoshimura, I., Heston, W.D.W., Gansbacher, B., and Fair, W.R.

Subjects
Prostate cancer -- Models, Gene therapy -- Research, Granulocyte-macrophage colony stimulating factor -- Physiological aspects, Business, Health care industry
Abstract

According to an abstract submitted by the authors to the 87th Annual Meeting of the American Association for Cancer Research, held April 20-24, 1996, in Washington, D.C., 'We have explored [...]

Published
1996

9. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells

Author

Yang, C.L., Cirirelli, C., Capogrossi, M.C., and Passaniti, A.

Subjects
Prostate cancer -- Genetic aspects, Gene therapy -- Research, Tumor suppressor genes -- Physiological aspects, Business, Health care industry
Abstract

According to the authors' abstract of an article published in Cancer Research, 'The use of replication-deficient adenoviral vectors in gene therapy may become a powerful method to achieve efficient but [...]

Published
1995

10. Recent studies from Cornell University, Department of Medicine add new data to prostate cancer therapy

Subjects
Drugs -- Research, Drugs -- Physiological aspects, Prostate cancer -- Research, Prostate cancer -- Drug therapy, Prostate cancer -- Physiological aspects, Universities and colleges -- Physiological aspects, Antimitotic agents -- Research, Antimitotic agents -- Physiological aspects, Antineoplastic agents -- Research, Antineoplastic agents -- Physiological aspects, Oncology, Experimental -- Drug therapy, Oncology, Experimental -- Physiological aspects, Cancer -- Care and treatment, Cancer -- Physiological aspects, Cancer -- Research, Cancer -- Drug therapy
Abstract

New investigation results, '17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals,' are detailed in a study published in The Prostate (see also [...]

Published
2008

11. Reports from Toho University, Department of Urology describe recent advances in carcinoma therapy

Subjects
Medical research, Medicine, Experimental, Peptide hormones, Antineoplastic agents, Carcinoma, Cancer -- Care and treatment, ACTH, Universities and colleges, Antimitotic agents
Abstract

New investigation results, 'Cushing syndrome associated with prostatic tumor adrenocorticotropic hormone (ACTH) expression after maximal androgen blockade therapy,' are detailed in a study published in International Journal of Urology. 'We [...]

Published
2007

12. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer

Author

Vieweg, J., Boczkowski, D., Roberson, K.M., Edwards, D.W., Philip, M., Philip, R., Rudoll, T., Smith, C., Robertson, C., and Gilboa, E.

Subjects
Gene therapy -- Research, Prostate cancer -- Genetic aspects, Genetic vectors -- Usage, Business, Health care industry
Abstract

According to the authors' abstract of an article published in Cancer Research, 'We have shown previously that treatment of rats bearing the Dunning R3327 MatLyLu prostatic tumor with human interleukin [...]

Published
1995

13. Linomide therapy inhibits progression of prostatic cancers

Subjects
Prostate cancer, Neovascularization -- Prevention, Antineoplastic agents -- Physiological aspects, Business, Health care industry
Abstract

Linomide, a quinoline-3-carboxamide, inhibits prostatic tumor growth, researchers reported. Previous studies have shown that linomide has the ability to inhibit the growth rate of a series of androgen dependent and [...]

Published
1995

15. Researchers from University Medical Center Hamburg-Eppendorf Detail New Studies and Findings in the Area of Prostate Cancer (Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities)

Subjects
Oncology, Experimental -- Reports, Medical centers -- Reports -- Research, Tumors -- Research, Prostate cancer -- Research, Cancer -- Research, Health
Abstract

2024 FEB 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on prostate cancer is now available. According to news reporting [...]

Published
2024

16. Reports from Uniformed Services University of the Health Sciences Highlight Recent Research in Prostate Cancer (Abstract A048: The importance of time: Circadian rhythm disruption and prostate cancer)

Subjects
Oncology, Experimental -- Physiological aspects, Prostate cancer -- Physiological aspects, Cancer -- Physiological aspects -- Research, Health
Abstract

2023 JUN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on prostate cancer are discussed in a new report. According to [...]

Published
2023

17. Study Findings on Urology Described by Researchers at Hasanuddin University [A rare Prostatic Stromal Tumor - Stromal Tumor of Uncertain Malignant Potential (STUMP) and Prostatic Stromal Sarcomas (PSS) as cultural sexual health problem in a ...]

Subjects
Sarcoma -- Research, Cancer, Sexual disorders -- Research, Health
Abstract

2023 JUN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on urology. According to news reporting out of Hasanuddin [...]

Published
2023

21. 'Free Psa Antibodies As Diagnostics, Prognostics And Therapeutics For Prostate Cancer' in Patent Application Approval Process (USPTO 20230040245)

Subjects
Denosumab, Prostate cancer -- Genetic aspects, Biological products -- Genetic aspects -- Intellectual property, Antineoplastic agents -- Intellectual property, Cancer -- Care and treatment -- Genetic aspects, Antimitotic agents -- Intellectual property, Biotechnology industry, Health, Science and technology
Abstract

2023 FEB 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent application by the inventors Evans, Michael J. (New York, NY, US); [...]

Published
2023

22. Findings from University of Cincinnati Reveals New Findings on Prostate Cancer (Prostate Tumor Ron Receptor Signaling Mediates Macrophage Recruitment To Drive Androgen Deprivation Therapy Resistance Through Gas6-mediated Axl and Ron Signaling)

Subjects
Tumors -- Research, Prostate cancer -- Research, Androgens -- Research, Cancer -- Care and treatment, Macrophages -- Reports -- Research, Health, University of Cincinnati -- Reports
Abstract

2022 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting [...]

Published
2022

23. Research Data from Kafkas University Update Understanding of Biosensors (Detection of Circulating Prostate Cancer Cells Via Prostate Specific Membrane Antigen By Chronoimpedimetric Aptasensor)

Subjects
Oncology, Experimental, Medical equipment -- Research, Biosensors -- Research, Journalistic ethics -- Research, Prostate cancer -- Research, Cancer -- Diagnosis -- Research, Antigens -- Research, Physiological apparatus -- Research, Business, Health, Health care industry
Abstract

2022 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Biosensors. According to news reporting originating in Kars, Turkey, by [...]

Published
2022

24. Reports from University of Tehran Advance Knowledge in Prostate Cancer (A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer)

Subjects
Oncology, Experimental, Prostate cancer -- Risk factors -- Research, Metastasis -- Risk factors -- Research, PET imaging -- Research, Cancer -- Research, Health, University of Tehran
Abstract

2021 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on prostate cancer are presented in a new report. According to [...]

Published
2021

26. Patent Issued for Abiraterone Acetate Lipid Formulations (USPTO 10,722,527)

Subjects
Abiraterone -- Reports -- Intellectual property, Acetates -- Reports -- Intellectual property, Business, Health
Abstract

2020 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Williams, [...]

Published
2020

27. State University of Campinas (UNICAMP) Researchers Describe Research in Cell Biology (Polysaccharide Multilayer Films in Sensors for Detecting Prostate Tumor Cells Based on Hyaluronan-CD44 Interactions)

Subjects
Cells (Biology) -- Research, Biochemistry -- Research, Tumors -- Research, Sensors -- Research, Prostate cancer -- Research, Cytology -- Research, Hyaluronic acid -- Research, Biological sciences, Health, State University of Campinas
Abstract

2020 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- New research on cell biology is the subject of a new report. According to [...]

Published
2020

28. Preclinical efficacy of Genkyotex GKT831 in prostate cancer presented at ESUR18

Subjects
Prostate cancer, Medical schools, General interest, News, opinion and commentary
Abstract

Amsterdam: GENKYOTEX has issued the following news release: Genkyotex (Euronext Paris and Brussels: FR00011790542 - GKTX) (Paris: GKTX) (Brussels: GKTX), a biopharmaceutical company and leader in NOX therapies, today announces [...]

Published
2018

30. Sun Pharma Announces USFDA Approval of YONSA[R] (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone

Subjects
Methylprednisolone, Medical research, Medicine, Experimental, Steroids, Corticosteroids, Prostate cancer, Metastasis, Clinical trials, Pharmaceutical industry, Business, Business, international, Yonsa (Medication)
Abstract

YONSA ([R] ) was shown in clinical studies to be an effective form of abiraterone acetate, and can be taken with or without food, in combination with methylprednisolone Sun Pharma [...]

Published
2018

31. Churchill Pharmaceuticals Announces YONSA Clinical Data to be presented at ASCO GU in San Francisco

Subjects
Prostate cancer, Metastasis, Clinical trials, Business, Business, international, American Society of Clinical Oncology, Yonsa (Medication) -- Product development, Zytiga (Medication) -- Product development
Abstract

Data from pivotal STAAR trial published in the February 2018 issue of Urologic Oncology KING OF PRUSSIA, Pa. -- Churchill Pharmaceuticals LLC ('Churchill') today announced that positive data from the [...]

Published
2018

32. Patent Issued for System And Method For Real-Time Ultrasound Guided Prostate Needle Biopsies Using A Compliant Robotic Arm (USPTO 10,368,850)

Subjects
Siemens Medical Solutions USA Inc., Medical equipment industry -- Methods, Machine learning, Editors, Business, Health, Health care industry
Abstract

2019 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Siemens Medical Solutions USA Inc. (Malvern, Pennsylvania, United States) has been issued patent number 10,368,850, [...]

Published
2019

34. Data on Prostate Cancer Reported by Researchers at Zagazig University (68Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement)

Subjects
Positron emission tomography, Cancer research, Journalistic ethics, Prostate cancer, Antigens, Malaria, Anopheles, Tomography, Editors, Health
Abstract

2019 JUL 1 (NewsRx) -- By a News Reporter-Staff News Editor at Malaria Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating in [...]

Published
2019

36. Reports from Northwestern University Advance Knowledge in Prostatectomy (Physiologic Serum 1,25 Dihydroxyvitamin D Is Inversely Associated With Prostatic Ki67 Staining In a Diverse Sample of Radical Prostatectomy Patients)

Subjects
Surgery -- Reports, Tumors, Editors, Medical equipment, Health, Northwestern University -- Reports
Abstract

2019 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Device Business Week -- New research on Surgery - Prostatectomy is the subject of a report. According [...]

Published
2019

37. Reports from Zhejiang University Provide New Insights into Angiomyxoma (Aggressive angiomyxoma of the prostate)

Subjects
Prostate cancer -- Diagnosis -- Care and treatment -- Case studies -- Reports, Transurethral prostatectomy -- Usage -- Reports, Hypertrophy, Tumors, Myxoma, Prostatic hyperplasia, Editors, Health
Abstract

2019 FEB 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Oncology - Angiomyxoma are presented in a new report. According [...]

Published
2019

38. New Prostatic Hyperplasia Findings from University of A Coruna Described (Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth)

Subjects
Prostatic hyperplasia -- Models, Computer simulation -- Models, Prostate cancer -- Models, Medical research -- Models, Cancer research, Hyperplasia, Editors, Business, Health, Health care industry, National Academy of Sciences
Abstract

2019 FEB 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Urogenital Diseases and Conditions - Prostatic HyperplAsia. According to news [...]

Published
2019

39. Study Data from Monash University Provide New Insights into Tissue Engineering [Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric ...]

Subjects
Tissue engineering -- Analysis, Medical research -- Analysis, Prostate cancer -- Analysis, Tumors, Biomedical engineering, Editors, Business, Health, Health care industry, Monash University
Abstract

2019 JAN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Biomedical Engineering - Tissue Engineering are presented in a new report. According [...]

Published
2019

41. A Randomized Phase III Study - Conventional Androgen Deprivation Therapy With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and Androgen Deprivation Therapy

Subjects
Prostate specific antigen -- Physiological aspects -- Research, Prostate cancer -- Genetic aspects -- Drug therapy -- Research, Androgen suppression therapy -- Usage -- Research, Health
Abstract

2019 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Staff editors report on the newly launched clinical trial, NCT03777982, which has the [...]

Published
2019

42. Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA

Subjects
United States. Food and Drug Administration, Prostate cancer -- Care and treatment, Testosterone, Business, News, opinion and commentary, Yonsa (Medication), Zytiga (Medication)
Abstract

The NDA contains data to support approval for YONSA, (abiraterone acetate) ultramicrosize tablets, for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Churchill Pharmaceuticals also announces positive results from the [...]

Published
2017

43. Churchill Pharmaceuticals Expands Commercial Leadership Team

Subjects
Executives, Business, News, opinion and commentary
Abstract

KING OF PRUSSIA, Pa., May 30, 2017 /PRNewswire/ -- Churchill Pharmaceuticals, LLC (Churchill), a clinical-stage biopharmaceutical company, today announced the expansion of their Commercial Leadership Team. These Churchill Commercial Leadership [...]

Published
2017

44. Churchill Pharmaceuticals Announces Submission of NDA for Novel Oral Formulation of Prostate Cancer Treatment

Subjects
United States. Food and Drug Administration, Methylprednisolone, Corticosteroids, Prostate cancer -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Care and treatment, Business, News, opinion and commentary, Zytiga (Medication)
Abstract

KING OF PRUSSIA, Pa., May 23, 2017 /PRNewswire/ -- Churchill Pharmaceuticals, LLC (Churchill) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration [...]

Published
2017

45. Sun Pharma Announces USFDA Approval of YONSA[R] abiraterone acetate To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone

Subjects
Periodical publishing, Steroids (Organic compounds), Glucocorticoids, Drug approval, Pharmaceutical industry, Cancer metastasis -- Drug therapy, Methylprednisolone, General interest
Abstract

2018 JUN 5 (VerticalNews) -- By a News Reporter-Staff News Editor at Journal of India -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, 'Sun [...]

Published
2018

46. US FDA Grants Approval to Sun Pharma Subsididary for Yonsa (abiraterone acetate) for Treatment of MCRPC in Combination with Methylprednisolone

Subjects
Methylprednisolone, Corticosteroids, Steroids, Prostate cancer -- Drug therapy, Drug approval, Pharmaceutical industry, Chemistry, Yonsa (Medication)
Abstract

M2 PHARMA-May 25, 2018-US FDA Grants Approval to Sun Pharma Subsididary for Yonsa (abiraterone acetate) for Treatment of MCRPC in Combination with Methylprednisolone (C)2018 M2 COMMUNICATIONS - Mumbai, India-based specialty [...]

Published
2018

47. Investigators at University of Iceland Detail Findings in Prostate Cancer (Thinking about one's own death after prostate-cancer diagnosis)

Subjects
Cancer diagnosis -- Health aspects, Prostate cancer -- Research -- Diagnosis -- Health aspects, Mental health services -- Health aspects, Health, Health care industry
Abstract

2018 APR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Data detailed on Oncology - Prostate Cancer have been presented. According [...]

Published
2018

48. New Findings from Northumbria University in Colorectal Research Provides New Insights (Automatic classification of colorectal and prostatic histologic tumor images using multiscale multispectral local binary pattern texture features and stacked ...)

Subjects
Tumors -- Research -- Diagnosis -- Analysis, Medical research -- Analysis, Health, Northumbria University
Abstract

2018 JAN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on Gastroenterology - Colorectal Research have been published. According to news [...]

Published
2018

49. Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA by the U.S. FDA

Subjects
United States. Food and Drug Administration, Drugs -- Prescribing, Business, Pharmaceuticals and cosmetics industries, Health, Yonsa (Medication)
Abstract

2017 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Churchill Pharmaceuticals, LLC (Churchill), a privately held company devoted to expanding treatment options with [...]

Published
2017

50. Churchill Pharmaceuticals Expands Commercial Leadership Team

Subjects
Vice presidents (Organizations), Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2017 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Churchill Pharmaceuticals, LLC (Churchill), a clinical-stage biopharmaceutical company, announced the expansion of their Commercial [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results